APEX’s Pro-care Turn relieves caregivers’ burden. (source: organizer)

Developed by APEX Medical Corporation (APEX), Pro-care Turn is a lateral turning mattress that enhances pressure relief for bedridden patients and relieves caregivers’ burden. Currently, Pro-care Turn has been sold in more than 60 countries around the world, with the global sales reaching nearly US$30 million last year. Founded in 1990, APEX has become a patient-focused, innovation-driven global medical solution provider during the development over three decades. APEX wins the Go-Global Award - Silver Medal Award in the 2020 Taipei Biotech Awards for Pro-care Turn.

As a medical mattress manufacturer, APEX (4106) provides a complete product line for households and medical institutions, from stage 0 to stage IV for pressure ulcer prevention and treatment, to meet various needs in the market. APEX boasts a number of key technologies and component development technologies, including physiological signal sensing, small signal processing, real-time algorithm, and medical blowers, along with clinical validation. In the medical device industry that requires a significant amount of investment in time, money, and manpower for various and small amount production, APEX invests considerable manpower and money in expanding R&D equipment and introducing new technologies every year to continue innovation.

According to statistics, the average cost of pressure ulcer treatment in Australia, the United Kingdom and the United States ranges from US$8,990 to US$40,000 per case. Studies also indicate that the use of pressure relief products for early prevention can save about 80% of medical and labor costs.

With years of industry experience, APEX has been studying the causes of pressure ulcers and clinical prevention methods and has found out that redistribution is one of the market needs that have not been met. Therefore, Pro-Care Turn is developed for the purpose of further enhancing pressure relief.

APEX’s Pro-care Turn features various and integrated technologies under the guidance of consultants from the industry and academic and research institutions. Breaking through innovation bottlenecks, APEX masters core technologies and clinical research on pressure relief products to further the research and development of future-proof technologies.  

With an effective, comfortable and safe design that meets users’ needs, APEX’s Pro-care Turn provides full protection against bacteria to reduce the risk of cross-infection; it also helps relieve caregivers’ burden and improve quality care while maintaining patients’ dignity and coziness. Suitable for hospitals and health care institutions, Pro-care Turn is a pressure ulcer prevention and treatment system that can reduce overall medical costs. To reduce medical costs and meet the users’ needs, APEX is eyeing the health insurance market and the leasing market.At present, APEX has established subsidiaries in the United States, Spain, China, the United Kingdom, France, Germany and Thailand to secure market presence in Europe, America, and Southeast Asia. A representative office in Egypt is also in place to serve customers in the Middle East, Southwest Asia, and Africa. APEX has 142 agents and 3,500 retailers around the world targeting long-term care centers and medical institutions. It also outplays competitors through tenders to become the first choice for customers.